Ignite Creation Date:
2024-05-06 @ 3:18 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04591002
Status:
WITHDRAWN
Last Update Posted:
2023-05-12
First Post:
2020-09-08
Brief Title:
Osimertinib to Suppress the Progression of GGNEGFR Mutation-positive
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
ESR-19-20085
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Samsung Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Se-Hoon Lee
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None